vs
MGIC INVESTMENT CORP（MTG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
MGIC INVESTMENT CORP的季度营收约是REPLIGEN CORP的1.5倍（$297.1M vs $197.9M），MGIC INVESTMENT CORP净利率更高（55.6% vs 6.7%，领先48.9%），REPLIGEN CORP同比增速更快（13.6% vs -3.0%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -1.4%）
MGIC投资集团（纽交所代码：MTG）是美国专业的私人抵押贷款保险服务商，总部位于威斯康星州密尔沃基市，主要为美国本土住房抵押贷款业务提供保险解决方案，帮助贷款机构管控信用风险，助力普通消费者顺利获得购房贷款支持。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MTG vs RGEN — 直观对比
营收规模更大
MTG
是对方的1.5倍
$197.9M
营收增速更快
RGEN
高出16.6%
-3.0%
净利率更高
MTG
高出48.9%
6.7%
两年增速更快
RGEN
近两年复合增速
-1.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $297.1M | $197.9M |
| 净利润 | $165.3M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 55.6% | 6.7% |
| 营收同比 | -3.0% | 13.6% |
| 净利润同比 | -10.9% | 143.9% |
| 每股收益（稀释后） | $0.76 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTGRGEN
| Q1 26 | $297.1M | — | ||
| Q4 25 | $298.7M | $197.9M | ||
| Q3 25 | $304.5M | $188.8M | ||
| Q2 25 | $304.2M | $182.4M | ||
| Q1 25 | $306.2M | $169.2M | ||
| Q4 24 | $301.4M | $174.1M | ||
| Q3 24 | $306.6M | $154.9M | ||
| Q2 24 | $305.3M | $154.1M |
净利润MTGRGEN
| Q1 26 | $165.3M | — | ||
| Q4 25 | $169.3M | $13.3M | ||
| Q3 25 | $191.1M | $14.9M | ||
| Q2 25 | $192.5M | $14.9M | ||
| Q1 25 | $185.5M | $5.8M | ||
| Q4 24 | $184.7M | $-30.3M | ||
| Q3 24 | $200.0M | $-654.0K | ||
| Q2 24 | $204.2M | $3.3M |
毛利率MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 71.2% | 9.0% | ||
| Q3 25 | 77.2% | 8.9% | ||
| Q2 25 | 80.9% | 7.6% | ||
| Q1 25 | 76.6% | 3.9% | ||
| Q4 24 | 77.9% | -17.7% | ||
| Q3 24 | 82.9% | -5.1% | ||
| Q2 24 | 85.1% | 1.0% |
净利率MTGRGEN
| Q1 26 | 55.6% | — | ||
| Q4 25 | 56.7% | 6.7% | ||
| Q3 25 | 62.8% | 7.9% | ||
| Q2 25 | 63.3% | 8.2% | ||
| Q1 25 | 60.6% | 3.4% | ||
| Q4 24 | 61.3% | -17.4% | ||
| Q3 24 | 65.2% | -0.4% | ||
| Q2 24 | 66.9% | 2.2% |
每股收益（稀释后）MTGRGEN
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.75 | $0.24 | ||
| Q3 25 | $0.83 | $0.26 | ||
| Q2 25 | $0.81 | $0.26 | ||
| Q1 25 | $0.75 | $0.10 | ||
| Q4 24 | $0.71 | $-0.55 | ||
| Q3 24 | $0.77 | $-0.01 | ||
| Q2 24 | $0.77 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $235.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $5.0B | $2.1B |
| 总资产 | $6.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MTGRGEN
| Q1 26 | $235.1M | — | ||
| Q4 25 | $369.0M | $767.6M | ||
| Q3 25 | $266.9M | $748.7M | ||
| Q2 25 | $294.9M | $708.9M | ||
| Q1 25 | $207.0M | $697.2M | ||
| Q4 24 | $229.5M | $757.4M | ||
| Q3 24 | $288.6M | $784.0M | ||
| Q2 24 | $281.8M | $809.1M |
总债务MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MTGRGEN
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.1B | $2.1B | ||
| Q3 25 | $5.2B | $2.1B | ||
| Q2 25 | $5.2B | $2.1B | ||
| Q1 25 | $5.1B | $2.0B | ||
| Q4 24 | $5.2B | $2.0B | ||
| Q3 24 | $5.3B | $2.0B | ||
| Q2 24 | $5.1B | $2.0B |
总资产MTGRGEN
| Q1 26 | $6.4B | — | ||
| Q4 25 | $6.6B | $2.9B | ||
| Q3 25 | $6.6B | $2.9B | ||
| Q2 25 | $6.5B | $2.9B | ||
| Q1 25 | $6.5B | $2.9B | ||
| Q4 24 | $6.5B | $2.8B | ||
| Q3 24 | $6.7B | $2.8B | ||
| Q2 24 | $6.5B | $2.9B |
负债/权益比MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | $230.8M | $25.7M | ||
| Q3 25 | $215.4M | $48.1M | ||
| Q2 25 | $183.0M | $28.6M | ||
| Q1 25 | $223.7M | $15.0M | ||
| Q4 24 | $182.4M | $39.2M | ||
| Q3 24 | $182.9M | $49.3M | ||
| Q2 24 | $169.2M | $42.2M |
自由现金流MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | $230.2M | $17.6M | ||
| Q3 25 | $215.1M | $43.4M | ||
| Q2 25 | $183.0M | $21.5M | ||
| Q1 25 | $223.5M | $11.4M | ||
| Q4 24 | $181.9M | $33.6M | ||
| Q3 24 | $182.5M | $42.3M | ||
| Q2 24 | $169.0M | $37.4M |
自由现金流率MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 77.1% | 8.9% | ||
| Q3 25 | 70.6% | 23.0% | ||
| Q2 25 | 60.1% | 11.8% | ||
| Q1 25 | 73.0% | 6.8% | ||
| Q4 24 | 60.3% | 19.3% | ||
| Q3 24 | 59.5% | 27.3% | ||
| Q2 24 | 55.3% | 24.3% |
资本支出强度MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 4.1% | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.1% | 3.1% |
现金转化率MTGRGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.36× | 1.93× | ||
| Q3 25 | 1.13× | 3.23× | ||
| Q2 25 | 0.95× | 1.92× | ||
| Q1 25 | 1.21× | 2.57× | ||
| Q4 24 | 0.99× | — | ||
| Q3 24 | 0.91× | — | ||
| Q2 24 | 0.83× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
